AVITA MEDICAL, INC. (AVHHL) Return on equity 2017–2024
AVITA MEDICAL, INC. (AVHHL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1374.6%FY2024 · since FY2017: -90.8% → -1374.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1374.6% | -1302.5 pp |
| FY2023 | -72.1% | -40.7 pp |
| FY2022 | -31.5% | — |
| FY2020 | -23.0% | +35.1 pp |
| FY2019 | -58.1% | +62.4 pp |
| FY2018 | -120.5% | -29.7 pp |
| FY2017 | -90.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AVHHL financial trends
AVHHL RevenueAVHHL Net incomeAVHHL Net marginAVHHL Gross profitAVHHL Gross marginAVHHL Operating incomeAVHHL Operating marginAVHHL Operating cash flowAVHHL Free cash flowAVHHL Capital expendituresAVHHL Stock buybacksAVHHL Dividends paidAVHHL Total assetsAVHHL Total liabilitiesAVHHL Shareholders’ equityAVHHL overview →